New BIO chairwoman: Biotechnology has proud story to tell

04/29/2013 | Washington Post, The

The biotechnology sector needs to share its health care accomplishments with consumers and lawmakers, highlighting the contributions it makes through drug development, newly elected BIO chairwoman Rachel King said. "Most people have probably benefited or know someone who has benefited. We need to communicate, as part of that, that to get to those new medicines takes a long time and a lot of investment," she said. King, the president and CEO of GlycoMimetics, said the FDA's efforts to hasten the approval process are crucial for limiting investor uncertainty and bringing new drugs to patients.

View Full Article in:

Washington Post, The

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Vice President, Idaho Regional Director
PacificSource
Boise, ID